Robeco Institutional Asset Management
PTCT icon

Robeco Institutional Asset Management’s PTC Therapeutics PTCT Stock Holding History

Robeco Institutional Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484K Sell
5,938
-314
-5% -$22.7K ﹤0.01% 781
2026
Q1 		$426K Buy
6,252
+432
+7% +$30.6K ﹤0.01% 798
2025
Q4 		$442K Buy
5,820
+87
+2% +$6.32K ﹤0.01% 778
2025
Q3 		$352K Hold
5,733
– – ﹤0.01% 819
2025
Q2 		$280K Buy
+5,733
New +$272K ﹤0.01% 831

Other funds holding PTCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Robeco Institutional Asset Management's PTCT Position: Q2 2026 in Review

Robeco Institutional Asset Management reduced its PTC Therapeutics (PTCT) stake by 5% in Q2 2026, selling an estimated $22.7K and leaving 5,938 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #781.

Robeco Institutional Asset Management first reported a position in PTCT in Q2 2025 and has held it in 5 quarters since. 73 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Robeco Institutional Asset Management held 5,938 shares of PTC Therapeutics worth $484K as of Q2 2026.
  • Robeco Institutional Asset Management sold 314 PTC Therapeutics shares in Q2 2026, an estimated $22.7K.
  • PTC Therapeutics made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #781 holding.
  • Robeco Institutional Asset Management first reported a position in PTC Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 73 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.